Numinus Wellness gets Health Canada approval for open-label study for MDMA-Assisted Therapy for PTSD

Numinus Wellness Medical and Therapeutic Services Director for Numinus Dr. Devon Christie joined Steve Darling from Proactive to announce Health Canada has cleared an open-label safety and feasibility study evaluating MDMA-assisted therapy for post-traumatic stress disorder. Dr Christie, who will serve as the study’s Qualified Investigator, tells Proactive during the study, research, medical and therapist staff… Read More »
 •  0 comments  •  flag
Share on Twitter
Published on July 28, 2021 00:38
No comments have been added yet.